Get the Stockscreener App
4.13
0.60%
-0.025
Athira Pharma Inc stock is traded at $4.13, with a volume of 6,766.
It is down -0.60% in the last 24 hours and down -0.24% over the past month.
Athira Pharma Inc is a late clinical-stage biopharmaceutical company focused on developing small molecules engineered to restore neuronal health and slow neurodegeneration. Its pipeline candidates are; Fosgonimeton (ATH-1017) is a small molecule drug candidate designed to enhance the activity of the neurotrophic hepatocyte growth factor (HGF) system; ATH-1020 a novel, orally available, next-generation small molecule drug candidate designed to positively modulate the neurotrophic HGF system; ATH-1105 is a novel, orally available, next-generation, small molecule drug candidate designed to positively modulate the neurotrophic HGF system.
See More
Previous Close:
$4.155
Open:
$3.9501
24h Volume:
6,766
Relative Volume:
0.07
Market Cap:
$16.39M
Revenue:
-
Net Income/Loss:
$-117.67M
P/E Ratio:
-1.3366
EPS:
-3.09
Net Cash Flow:
$-101.06M
1W Performance:
-0.48%
1M Performance:
-0.24%
6M Performance:
+1,334%
1Y Performance:
+581.63%
1-Day Range:
$3.95
$4.13
1-Week Range:
$3.95
$4.23
52-Week Range:
$0.2195
$4.59
Athira Pharma Inc Stock (ATHA) Company Profile
Name
Athira Pharma Inc
Sector
Industry
Phone
(425) 620-8501
Address
18706 NORTH CREEK PARKWAY, SUITE 104, BOTHELL
Compare ATHA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ATHA
Athira Pharma Inc
|
4.13 | 16.39M | 0 | -117.67M | -101.06M | -3.09 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.08 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
641.99 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
432.26 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
822.85 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
183.78 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Athira Pharma Inc Stock (ATHA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-19-24 | Downgrade | Mizuho | Outperform → Neutral |
| Sep-04-24 | Downgrade | BTIG Research | Buy → Neutral |
| Sep-04-24 | Downgrade | JMP Securities | Mkt Outperform → Mkt Perform |
| Sep-04-24 | Downgrade | Rodman & Renshaw | Buy → Neutral |
| Aug-19-24 | Initiated | Rodman & Renshaw | Buy |
| Oct-17-22 | Upgrade | JMP Securities | Mkt Perform → Mkt Outperform |
| Jul-07-22 | Initiated | Mizuho | Buy |
| Jun-23-22 | Downgrade | JMP Securities | Mkt Outperform → Mkt Perform |
| Jun-23-22 | Downgrade | Jefferies | Buy → Hold |
| Jun-23-22 | Downgrade | Stifel | Buy → Hold |
| May-10-22 | Initiated | BTIG Research | Buy |
| Apr-21-22 | Initiated | Berenberg | Buy |
| Dec-15-21 | Initiated | Goldman | Neutral |
| Oct-13-20 | Initiated | Goldman | Buy |
| Oct-13-20 | Initiated | JMP Securities | Mkt Outperform |
| Oct-13-20 | Initiated | Jefferies | Buy |
| Oct-13-20 | Initiated | Stifel | Buy |
View All
Athira Pharma Inc Stock (ATHA) Latest News
Will Athira Pharma Inc. stock benefit from AI adoptionWeekly Profit Summary & Free Weekly Watchlist of Top Performers - newser.com
Will Athira Pharma Inc. continue its uptrendEarnings Beat & AI Enhanced Trading Alerts - newser.com
Why Athira Pharma Inc. stock is popular among millennialsJuly 2025 Trends & Safe Capital Growth Plans - newser.com
Real time alert setup for Athira Pharma Inc. performanceMarket Risk Analysis & Low Risk Investment Opportunities - newser.com
Can Athira Pharma Inc. stock deliver consistent earnings growth2025 EndofYear Setup & Consistent Income Trade Recommendations - newser.com
Athira Pharma Inc. stock volume spike explainedQuarterly Portfolio Report & Expert Approved Momentum Ideas - newser.com
Risk vs reward if holding onto Athira Pharma Inc.Dollar Strength & Free Reliable Trade Execution Plans - newser.com
Is Athira Pharma Inc. stock ready for breakoutTrade Risk Assessment & Proven Capital Preservation Methods - newser.com
Is Athira Pharma Inc. stock cheap at current valuationSell Signal & AI Enhanced Trade Execution Alerts - newser.com
Athira Pharma Inc. stock outlook for YEARGap Up & High Accuracy Investment Signals - newser.com
Published on: 2025-11-01 11:59:10 - newser.com
What indicators show strength in Athira Pharma Inc.2025 Price Action Summary & Verified Technical Signals - newser.com
What analyst consensus says on Athira Pharma Inc. stockWeekly Gains Summary & Breakout Confirmation Trade Signals - newser.com
Published on: 2025-10-31 05:52:18 - newser.com
Top chart patterns to watch in Athira Pharma Inc.Options Play & Real-Time Volume Spike Alerts - newser.com
What analysts say about Athira Pharma Inc stockFederal Reserve Announcements & Learn From the Strategies of Institutions - earlytimes.in
What makes Athira Pharma Inc. stock attractive to growth fundsRate Cut & High Conviction Buy Zone Alerts - newser.com
How to use a screener to detect Athira Pharma Inc. breakoutsTrade Exit Report & Safe Capital Growth Plans - newser.com
Athira Pharma Inc Stock (ATHA) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.27%
0.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):